Valuation: Treace Medical Concepts, Inc.

Market Cap 278M 243M 224M 207M 393M 26.5B 400M 2.68B 1.05B 13.01B 1.04B 1.02B 45.08B P/E 2026 *
-4.75x
P/E 2027 * -5.12x
Enterprise Value 323M 282M 260M 241M 457M 30.8B 465M 3.12B 1.22B 15.13B 1.21B 1.19B 52.4B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.65x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day+8.88%
1 week+10.17%
Current month+17.09%
1 month+32.01%
3 months+232.86%
6 months+57.43%
Current year+90.20%
1 week 4.13
Extreme 4.1317
4.7
1 month 3.73
Extreme 3.73
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.22
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 64 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
+8.88%+10.17%-24.35%-79.96% 278M
+0.21%+0.48%+28.31%-2.88% 12.48B
-0.03%-1.66%+63.02%+34.88% 5.99B
+1.60%+0.25%+5.23%+13.32% 5.6B
+0.20%-0.92% - - 4.22B
+4.52%+3.68%-31.78%+10.98% 3.92B
-0.58%-2.03%-26.81%-27.99% 3.77B
-0.46%+9.57%-1.26%-57.91% 2.01B
0.00%+5.06%+22.20%+269.27% 1.87B
+2.00%+3.76%+60.13%-4.08% 1.53B
Average +1.63%+1.86%+10.52%+17.29% 4.17B
Weighted average by Cap. +0.78%+0.44%+17.59%+14.55%

Financials

2026 *2027 *
Net sales 206M 180M 166M 154M 292M 19.69B 297M 1.99B 781M 9.67B 774M 758M 33.49B 222M 194M 179M 166M 314M 21.17B 319M 2.14B 840M 10.4B 833M 815M 36.01B
Net income -58.31M -51.01M -47.04M -43.52M -82.6M -5.57B -83.98M -563M -221M -2.73B -219M -214M -9.47B -54.66M -47.82M -44.09M -40.8M -77.44M -5.22B -78.73M -528M -207M -2.56B -205M -201M -8.87B
Net Debt 45.05M 39.41M 36.34M 33.63M 63.83M 4.3B 64.89M 435M 171M 2.11B 169M 165M 7.31B 88.04M 77.02M 71.03M 65.72M 125M 8.4B 127M 851M 333M 4.13B 331M 323M 14.29B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-09 US$4.660 +8.88% 475,493
26-07-08 US$4.280 -2.95% 480,749
26-07-07 US$4.410 -3.29% 624,865
26-07-06 US$4.560 +8.31% 662,392
26-07-02 US$4.210 -0.47% 460,661
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.280USD
Average target price
4.000USD
Spread / Average Target
-6.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock